ClinicalTrials.Veeva

Menu
D

Dragonfly Research, LLC | Wellesley, MA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ocrelizumab
Ofatumumab
Interferon
ATA188
Natalizumab
Fenebrutinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 12 total trials

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis (OLIKOS)

A single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis who are tra...

Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Ofatumumab

A study to evaluate the efficacy and safety of fenebrutinib on disability progression in adult participants with Primary Progressive Multiple Scleros...

Active, not recruiting
Multiple Sclerosis, Primary Progressive
Drug: Placebo matched to ocrelizumab
Drug: Placebo matched to fenebrutinib

This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and pharmacokinetics of a higher dose...

Active, not recruiting
Multiple Sclerosis
Drug: Antihistamine
Drug: Ocrelizumab

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have particip...

Enrolling
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Trial sponsors

Roche logo
Novartis logo
Genentech logo
A
Biogen logo
D

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems